The big business of Australian IVF
A second Australian IVF company wil float on the stock exchange today.
A second Australian IVF company wil float on the stock exchange today. Investment analysts believe that Monash IVF will have a market capitalisation of about A$427 million. Its rival, Virtus Health, is capitalised at $694 million. This means that Australian IVF is at least a $1 billion business. As capital markets expert Paul Docherty explains in this interview in The Conversation, IVF is an attractive investment for institutional investors in Australia because it helps them to diversify their portfolio.
https://www.bioedge.org/images/2008images/TH_busines_of_IVF.jpg
Creative commons
Australia
commercialization
IVF
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicideāagain - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Are Dutch doctors too willing to euthanise people with autism and intellectual disability?
Will legalized euthanasia and assisted suicide lead to unnecessary deaths because of an able-ist bias against intellectual disability and autism?...
Euthanasia in Quebec: seamless service at a friendly funeral parlour
In Quebec, the number of cases of euthanasia has risen from 63 in 2015-2016 to 3663 in 2021-2022. Nowadays many...
Against commercial-assisted suicide
The journal Bioethics recently published an attack on commercial assisted suicide (CAS). The author, Yoann Della Croce, condemns it as...
Norway to export sperm
Danish sperm banks have grown into a successful export industry. Now Norway seems to be following the same path. The...
Denmark: parliament pressured to OK euthanasia
A proposal to legalise euthanasia in Denmark has broken the threshold of 50,000 signatures to put it before the Danish...
Australian judges need to review standards for gender dysphoria treatment
Most judges and lawyers in Australia know little about the white-hot debate amongst doctors over appropriate treatment for gender-dysphoric children....